Matusow Truth Blog

In connection with www.makepokerlegal.com. Myself, Scott Matusow, and from time to time, Mike "The Mouth" Matusow will be blogging here. All you want to know here.. Enjoy our blog; Scott Matusow

Friday, March 30, 2012

Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha

Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha
Posted by Scott Matusow at 6:13 AM No comments:

Thursday, March 29, 2012

Thursday's Bio-Pharma Movers And Picks List - Seeking Alpha

Thursday's Bio-Pharma Movers And Picks List - Seeking Alpha
Posted by Scott Matusow at 6:20 AM No comments:

Monday, March 26, 2012

Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha

Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha
Posted by Scott Matusow at 6:56 AM No comments:

Friday, March 23, 2012

4 Biopharma Swing Trades For The Mid Term - 3 Week Report Card - Seeking Alpha

4 Biopharma Swing Trades For The Mid Term - 3 Week Report Card - Seeking Alpha
Posted by Scott Matusow at 9:59 AM No comments:

Stocks on the Road to Greatness (YPF)

Stocks on the Road to Greatness (YPF)
Posted by Scott Matusow at 2:39 AM No comments:

Wednesday, March 21, 2012

Ariad Pharma Sees Huge Setback In Its Sarcoma Maintenance Drug Ridaforolimus - Seeking Alpha

Ariad Pharma Sees Huge Setback In Its Sarcoma Maintenance Drug Ridaforolimus - Seeking Alpha
Posted by Scott Matusow at 5:18 AM No comments:

Tuesday, March 20, 2012

Large Pharmas Catching On To Acura Pharmaceuticals' Remarkable Potential - Seeking Alpha

Large Pharmas Catching On To Acura Pharmaceuticals' Remarkable Potential - Seeking Alpha
Posted by Scott Matusow at 3:33 AM No comments:

Monday, March 19, 2012

A Review Of My Last 3 Small Cap Bio-Pharma Picks - Seeking Alpha

A Review Of My Last 3 Small Cap Bio-Pharma Picks - Seeking Alpha
Posted by Scott Matusow at 12:01 PM No comments:

Friday, March 16, 2012

Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha

Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha
Posted by Scott Matusow at 3:23 PM No comments:

Wednesday, March 14, 2012

NuPathe Pharma: A Possible Double On The Horizon - Seeking Alpha

NuPathe Pharma: A Possible Double On The Horizon - Seeking Alpha
Posted by Scott Matusow at 9:08 AM No comments:

Wednesday, March 7, 2012

Near-Term Stock Catalysts For These Bio-Pharmas - Seeking Alpha

Near-Term Stock Catalysts For These Bio-Pharmas - Seeking Alpha
Posted by Scott Matusow at 10:09 AM No comments:

Tuesday, March 6, 2012

MELA Sciences: A Hidden Gem That Could Bring A Stock Price Double This Year - Seeking Alpha

MELA Sciences: A Hidden Gem That Could Bring A Stock Price Double This Year - Seeking Alpha
Posted by Scott Matusow at 10:19 AM No comments:

Monday, March 5, 2012

4 Biopharma Swing Trades For The Mid Term - Seeking Alpha

4 Biopharma Swing Trades For The Mid Term - Seeking Alpha
Posted by Scott Matusow at 9:44 AM No comments:

Friday, March 2, 2012

4 Small-Cap, High-Risk, High-Reward Bio-Pharmas - Seeking Alpha

4 Small-Cap, High-Risk, High-Reward Bio-Pharmas - Seeking Alpha
Posted by Scott Matusow at 7:42 AM No comments:
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Come join our free Poker Room. Tons of cash and prizes!

Come join our free Poker Room. Tons of cash and prizes, and it is free! Vip Memberships also available with even more Cash and Prizes!

Blog Archive

  • ►  2017 (1)
    • ►  January (1)
  • ►  2015 (5)
    • ►  May (2)
    • ►  April (1)
    • ►  February (1)
    • ►  January (1)
  • ►  2014 (38)
    • ►  December (4)
    • ►  November (1)
    • ►  September (2)
    • ►  August (4)
    • ►  July (2)
    • ►  June (5)
    • ►  May (5)
    • ►  March (3)
    • ►  February (4)
    • ►  January (8)
  • ►  2013 (71)
    • ►  December (2)
    • ►  November (3)
    • ►  October (7)
    • ►  September (3)
    • ►  August (3)
    • ►  July (1)
    • ►  June (1)
    • ►  May (10)
    • ►  April (7)
    • ►  March (12)
    • ►  February (10)
    • ►  January (12)
  • ▼  2012 (160)
    • ►  December (17)
    • ►  November (18)
    • ►  October (9)
    • ►  September (4)
    • ►  August (11)
    • ►  July (7)
    • ►  June (11)
    • ►  May (15)
    • ►  April (13)
    • ▼  March (14)
      • Bio-Pharma Drug Approval Watch List: Final Results...
      • Thursday's Bio-Pharma Movers And Picks List - Seek...
      • Alimera Sciences: An Upcoming Catalyst Should Make...
      • 4 Biopharma Swing Trades For The Mid Term - 3 Week...
      • Stocks on the Road to Greatness (YPF)
      • Ariad Pharma Sees Huge Setback In Its Sarcoma Main...
      • Large Pharmas Catching On To Acura Pharmaceuticals...
      • A Review Of My Last 3 Small Cap Bio-Pharma Picks -...
      • Why Antares Pharma Should Be On Your List For Long...
      • NuPathe Pharma: A Possible Double On The Horizon -...
      • Near-Term Stock Catalysts For These Bio-Pharmas - ...
      • MELA Sciences: A Hidden Gem That Could Bring A Sto...
      • 4 Biopharma Swing Trades For The Mid Term - Seekin...
      • 4 Small-Cap, High-Risk, High-Reward Bio-Pharmas - ...
    • ►  February (23)
    • ►  January (18)
  • ►  2011 (137)
    • ►  November (6)
    • ►  October (3)
    • ►  September (6)
    • ►  August (2)
    • ►  July (2)
    • ►  June (12)
    • ►  May (6)
    • ►  April (23)
    • ►  March (34)
    • ►  February (23)
    • ►  January (20)
  • ►  2010 (27)
    • ►  December (16)
    • ►  November (10)
    • ►  April (1)
  • ►  2009 (4)
    • ►  May (2)
    • ►  April (2)
  • ►  2008 (8)
    • ►  October (1)
    • ►  July (3)
    • ►  June (4)
  • ►  2007 (124)
    • ►  November (3)
    • ►  October (3)
    • ►  September (1)
    • ►  August (5)
    • ►  July (10)
    • ►  June (57)
    • ►  May (4)
    • ►  April (1)
    • ►  March (20)
    • ►  February (20)

Contributors

  • Mike Matusow
  • Scott Matusow

Vistors

Free Web Counter
Free Web Counter